Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
The 150-year-old drugmaker is the first company in health care [...]
RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugs
The weight loss medicines are proving to be a test [...]
Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
The announcement of the deal signaled an end to the [...]
What Trump’s New Drug Pricing Deal Means for People With Obesity
The president’s agreement with drug companies involves a range of [...]
Targeting Hims & Hers, F.D.A. Takes on a New Type of Drug Advertiser
Regulators sent about 100 warning letters this week to drug [...]
Trump Moves to Crack Down on Drug Advertising
The administration is proposing a return to a 1990s-era policy [...]
Trump Demands That Drugmakers Lower Some of Their U.S. Prices by September
The administration has not put forward a clear legal authority [...]
Trump’s ‘Beautiful Bill’ Actually Pushes Manufacturing Abroad
A loophole in Trump’s policy bill would continue to encourage [...]
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
CVS Caremark decided to stop offering Zepbound in favor of [...]
Sybil Shainwald, Lawyer Who Fought for Women’s Health, Dies at 96
After taking part in a landmark case against the manufacturers [...]